UBS Group AG

Holdings History for Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Symbol: TERN on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0.01%	$13,169,107	325,968	-646,804	-66%	$40.40	Q4 2025
30 Sep 2025	0%	-0%	$7,305,517	972,772	-198,847	-17%	$7.51	Q3 2025
30 Jun 2025	0%	+0%	$4,370,138	1,171,619	+238,513	+26%	$3.73	Q2 2025
31 Mar 2025	0%	+0%	$2,575,372	933,106	+531,448	+100%	$2.76	Q1 2025
31 Dec 2024	0%	+0%	$2,225,186	401,658	+332,260	+479%	$5.54	Q4 2024
30 Sep 2024	0%	-0%	$578,780	69,398	-17,934	-21%	$8.34	Q3 2024
30 Jun 2024	0%	+0%	$594,731	87,332	+24,563	+39%	$6.81	Q2 2024
31 Mar 2024	0%	-0%	$411,764	62,769	-45,706	-42%	$6.56	Q1 2024
31 Dec 2023	0%	+0%	$704,003	108,475	+86,931	+404%	$6.49	Q4 2023
30 Sep 2023	0%	-0%	$108,366	21,544	-31,531	-59%	$5.03	Q3 2023
30 Jun 2023	0%	+0%	$464,407	53,075	+47,403	+836%	$8.75	Q2 2023
31 Mar 2023	0%	+0%	$67,157	5,672	+5,672	NEW	$11.84	Q1 2023
31 Dec 2022		-0%	$0	0	-3,667	-100%	$35.34	Q4 2022
30 Sep 2022	0%	+0%	$22,000	3,667	+3,667	NEW	$6.00	Q3 2022
31 Mar 2022		-0%	$0	0	-3,775	-100%	$35.34	Q1 2022
31 Dec 2021	0%	+0%	$27,000	3,775	+3,775	NEW	$7.15	Q4 2021
30 Jun 2021		-0%	$0	0	-2,546	-100%	$35.34	Q2 2021
31 Mar 2021	0%	+0%	$56,000	2,546	+2,546	NEW	$22.00	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.